8 patents
Utility
Oral Formulations of Bipolar Trans Carotenoids
2 Nov 23
The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a bipolar trans carotenoid, ii) a cyclodextrin, and iii) a coating.
John L. Gainer, Robert Murray
Filed: 7 Nov 22
Utility
Trans Carotenoids, Their Synthesis, Formulation and Uses
8 Dec 22
The invention relates to trans carotenoid compounds and salts thereof as well as compositions thereof, methods for making them, and uses thereof.
John L. Gainer, Marc Lanz
Filed: 31 Jan 22
Utility
Oral formulations of bipolar trans carotenoids
8 Nov 22
The subject invention relates to a variety of formulations of bipolar trans carotenoids including pharmaceutical compositions for oral delivery of a bipolar trans carotenoid comprising i) a bipolar trans carotenoid, ii) a cyclodextrin, and iii) a coating.
John L. Gainer, Robert Murray
Filed: 9 Jul 18
Utility
Use of Bipolar Trans Carotenoids with Chemotherapy and Radiotherapy for Treatment of Cancer
25 Aug 22
The subject disclosure relates to compounds and compositions including chemotherapy agents and/or radiation therapy with bipolar trans carotenoids, and the use of such compounds for the treatment of various cancers including pancreatic and brain cancers.
John L. GAINER
Filed: 31 Oct 21
Utility
Trans carotenoids, their synthesis, formulation and uses
22 Mar 22
The invention relates to trans carotenoid compounds and salts thereof as well as compositions thereof, methods for making them, and uses thereof.
John L. Gainer, Marc Lanz
Filed: 20 Mar 18
Utility
Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
30 Nov 21
The subject disclosure relates to compounds and compositions including chemotherapy agents and/or radiation therapy with bipolar trans carotenoids, and the use of such compounds for the treatment of various cancers including pancreatic and brain cancers.
John L. Gainer
Filed: 23 Mar 17
Utility
Diffusion enhancing compounds and their use alone or with thrombolytics
19 Oct 21
The subject invention relates to diffusion enhancing compounds and their use alone or with thrombolytic agents for the treatment of disorders resulting from the formation of a thrombus such as a myocardial infarction or stroke.
John L. Gainer
Filed: 16 Nov 18
Utility
Diffusion Enhancing Compounds and Their Use with Thrombectomy and Embolectomy and Other Vascular Disease Procedures
12 Aug 21
The subject invention relates to novel methods for the rapid treatment of disorders resulting from thrombosis or embolism such as a myocardial infraction or stroke.
David G. KALERGIS, Thomas BYRNE
Filed: 30 Jul 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first